Hamlet BioPharma invites you to our September investors’ meeting to be held on the 25th of September 2025, at 12:00.
Please click on the link below to...
Hamlet BioPharma, ticker Hamlet, the pharmaceutical company specializing in the development of drugs for cancer and infections, today announces the su...
Den 18 juli 2025 offentliggjorde styrelsen i Hamlet BioPharma AB AB (publ) beslut om en riktad emission av units bestående av aktier och teckningsopti...
Hamlet BioPharma, a global leader in the treatment of cancer and infections announces the successful granting of new patents, strengthening its intell...
Hamlet BioPharma, the pharmaceutical company, specializing in the development of drugs for cancer and infections, announces the PhD thesis defense by ...
Med anledning av pressmeddelanden och nyheter, bjuder Hamlet BioPharma in till en livesänd digital pressträff torsdag 28 augusti, 2025, klockan 12.00....
Hamlet BioPharma, the pharmaceutical company, specializing in the development of drugs for cancer and infections, announces the completion of the succ...
Lund, 11 augusti 2025, Hamlet BioPharma, ett innovativt läkemedelsbolag som utvecklar nya terapier mot cancer och infektioner, meddelar idag att extra...
Med anledning av pressmeddelanden och nyheter, bjuder Hamlet BioPharma in till en livesänd digital pressträff fredagen den 25 juli, 2025, klockan 11.3...
